AbbVie issues $4B in senior notes across four maturities to refinance near-term debt

AbbVie Inc.

Issued $1.25B 4.650% notes due 2028, $1B 4.875% due 2030, $1B 5.200% due 2035, $750M 5.600% due 2055.
Net proceeds ~$3.98B after underwriting discounts and expenses.
Proceeds plus cash on hand to repurchase or repay $3.75B 3.600% notes due May 2025 and/or $2.89B 3.800% notes due March 2025.
Closing expected February 26, 2025; underwriters include BofA, J.P. Morgan, Morgan Stanley, Barclays, Mizuho.
Offering also includes refinancing of $130M Allergan Funding 3.800% notes due March 2025 or general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.